First identified through a CRISPR/Cas9 screen in human epithelial lung cells, Daxx was found to translocate from the nucleus to the cytoplasm upon infection by SARS-CoV-2 and to inhibit its replication. In order to escape this restriction, the virus induces Daxx degradation through the viral protease PLPro encoded by Nsp3.
